why choose us

First received: March 10, 2023

Clinical Trial: Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Hypertension

Study Type: INTERVENTIONAL


Official Title: A Pilot Pre-Phase 1 Clinical Trial to Study How Administering Sublingual Nitric Oxide Donor S-nitroso-N-acetylcysteine Affects the Systemic Blood Pressure in Healthy Human Volunteers.

Brief Summary: The purpose of the study is to increase the in vivo levels of nitric oxide by generating nitric oxide donor compound S-nitrosoacetylcysteine (SNOAC) using the mixture of sodium nitrite and N-acetylcysteine crystals in the sublingual space.The generated SNOAC rapidly diffuses into blood circulation thereby decrease the systemic blood pressure.This compound can be an alternative to organic nitrate NO donor drugs without developing tolerance in patients.

Read more